Washington DC
Supernus Pharmaceuticals reports $20.9 million profit in Q3
Rockville-based Supernus Pharmaceuticals posted $20.9 million profit and 35 cents per share in third quarter earnings.
Photo: Jackson, William Henry / Public domain, via Wikimedia Commons
Supernus Pharmaceuticals Inc., headquartered in Rockville, Maryland, reported a profit of $20.9 million for its third quarter, according to WTOP.
The company announced earnings of 35 cents per share for the quarter. When adjusted for amortization costs and stock option expenses, earnings rose to 93 cents per share.
These results reflect the financial performance of the Rockville-based drugmaker for the recent quarter, as reported by the Associated Press via WTOP.
No additional guidance or future outlook was provided in the earnings snapshot released on Thursday.
Sources
We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.
Comments
No comments yet.
Sign in to comment